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Abstract
The 3Vuntranslated region (UTR) of rTSa RNA is complementary (i.e., antisense) to human thymidylate synthase (TS) RNA. When HEp2
cells (human epidermoid carcinoma) progressed from late-log to plateau phase growth, ribonuclease protection assay (RPA) revealed an
inverse correlation between the levels of rTSa RNA and TS mRNA, suggesting a possible effect of rTSa RNA on TS mRNA levels. HEp2
cells expressing a Tet-On transactivator were transiently co-transfected with pHook-1 and a construct containing rTSa (protein and antisense
RNA), rTSaD3V(rTSa protein only), rTSa-3V(antisense RNA–luciferase) or luciferase. Transfected cells were selected and evaluated for the
effects of induced transgene expression on TS mRNA. Induced expression of transfected rTSa or rTSa-3V, but not rTSaD3Vor luciferase,
resulted in decreased TS mRNA levels as measured by RPA. These results demonstrated that the antisense region of rTSa RNA is necessary
and sufficient for this down-regulation of TS mRNA. RPA for TS mRNA also showed the enhanced appearance of two partial-length protected
fragments in rTSa or rTSa-3Vtransfected cells. RPA stringency evaluations and primer extension assays indicated that TS mRNA is cleaved in
vivo in a site-specific manner. These data demonstrate that rTS gene expression likely plays a role in down-regulating TS through a natural
RNA-based antisense mechanism. D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Thymidylate synthase (TS, EC 2.1.1.45) is the enzyme
that catalyzes the methylation of deoxyuridylate to deoxy-
thymidylate (dTMP). This enzymatic reaction provides the
sole de novo intracellular source of dTMP, an essential
nucleotide precursor for DNA replication and repair. As a
result, TS has been a major target in cancer chemotherapy
for over 30 years [1]. Since some tumor cell lines resistant to
TS inhibitors overproduce the enzyme [2,3], a better under-
standing of mechanisms underlying the regulation of TS
levels is important for the development of cancer therapies
involving TS inhibition.
The TS gene is expressed at a much higher level in
rapidly proliferating cells than in nondividing cells [4–10].
However, nuclear run-on assays showed that the rate of the
TS gene transcription is relatively invariant as cells are
activated from a resting to a cycling state [5,11]. Therefore,
TS gene expression appears to be controlled mainly at the
posttranscriptional level in growth-stimulated cells [12].
Since growing cells are comprised of a large percentage of
cells in S phase, which generally parallels changes in TS
levels, TS appears to be an S-phase enzyme. This is
supported by the evidence that elevated expression of E2F
results in increased TS protein levels [13]. However, studies
on exponentially growing asynchronous cells have indicated
that the levels of TS mRNA [4], TS protein and TS activity
[6,10] fluctuate only within a narrow range throughout the
cell cycle, with the largest increase occurring during the G0/
G1 transition [6,10].
In 1993, our laboratory reported the discovery of a
naturally occurring antisense RNA to TS (now referred as
rTSa EMBL accession #X67098) [14]. The 3Vuntranslated
region (UTR) of rTSa mRNA is complementary (anti-
sense) to both TS pre-mRNA and TS mRNA (Fig. 1).
Natural antisense RNA was first discovered in prokaryotes
and has been demonstrated to exert negative control of
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gene expression at multiple levels, such as transcriptional
attenuation, interference with RNA processing, RNA desta-
bilization and translational inhibition [15]. Increasing num-
bers of naturally occurring antisense RNAs have been
identified in eukaryotes, raising the possibility that they
might play a role in the regulation of eukaryotic gene
expression [16,17]. However, in mammalian cells, the
functions of natural antisense RNAs in regulating the
expression of their counterpart (sense) genes have not been
established.
In the present study, we show that rTSa RNA and TS
mRNA levels vary inversely when cell growth transits from
late-log to plateau phase. We demonstrate that the antisense
portion of rTSa mRNA alone can down-regulate TS mRNA
levels in transiently transfected cells. Our data also show
that this down-regulation is associated with increased site-
specific cleavage of TS mRNA.
2. Experimental procedures
2.1. Plasmids and probes
The plasmids for the Tet-On gene expression system
(pUHD 172-1 neo, pUHD 10-3 and pUHC13-3) were
obtained from Dr. Hermann Bujard [18]. To construct the
expression vector for rTSa, we cloned the EcoRI–HindIII
fragment of rTSa containing the full-length cDNA into the
EcoRI and XbaI sites of pUHD10-3. The HindIII site of the
rTSa insert and XbaI site of pUHD10-3 were partially filled
Fig. 1. (A) The relationship between the rTSamRNA and the TS gene/pre-mRNA. The protein coding region and 3VUTR of rTSa are indicated by an open box
and a solid line, respectively. The two boxes in the TS pre-mRNA represent a portion of intron VI and the protein coding region of exon 7 as indicated. The 3VUTR
of exon 7 is indicated by a solid line. The rest of TS pre-mRNA is represented by a dotted line. Numbers represent nucleotide distance either from the 5Vend of the
rTSaRNA or over the spans indicated by double arrows. rTSamRNA is complementary to TS pre-mRNA over a span of 523 nt, including the first A of the rTSa
poly (A) tail. The targeted region (285 nt) of the rTSa riboprobe is also indicated at the top. (B) Targeted region of the TS riboprobe and the expected cDNA
products from primer extension assay. Open boxes represent exons 5, 6 and 7 of TS mRNAwith the solid line representing the 3VUTR. The rest of the TS mRNA
is represented by a dotted line. The TS probe is represented by a solid line at the top. The full-length protected fragment would be 251 nt as indicated at the top. The
primer used in primer extension assays is represented by the left-facing arrow. ATS RNA editing site that generates a mismatch in the TS probe:mRNA duplex is
indicated by an asterisk (see Results and Discussion). The protected fragment in RPA resulting from cleavage at the editing site is 138 nt. The predicted length of
cDNA produced by primer extension from the TS mRNA cleaved at the editing site is 245 nt.
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in by Klenow enzyme (Life Technologies) to generate
cohesive ends. The expression vector for rTSa protein
without antisense RNA (rTSaD3V) was constructed by
cloning the EcoRI–BlpI (blunt-ended) fragment of the rTSa
cDNA into the EcoRI and XbaI sites (blunt-ended) of
pUHD 10-3. The 3VUTR was generated by PCR using
primers containing the StyI recognition sequence (boldface
type) (5V-primer: CGTGACCCCAAGGAAGTGCTCAGC-
CCCA-ACAACT, 3V-primer: GCGTGCTCCTTGGTGAC-
TGTGTTCCTGTCTTTAA). The vector for expressing
rTSa antisense RNA without rTSa protein (rTSa-3V) was
constructed by cloning the PCR generated fragment into the
StyI site of pUHC13-3. The sequences of all cloned cDNAs
were confirmed by sequencing at the RPCI Biopolymer
Facility.
The template for in vitro transcription used to generate
the TS riboprobe was SmaI linearized plasmid pTS-
PCRmut1 [19]. The targeted region of this TS probe
includes part of exon 5 (10 nt), exon 6 (72 nt) and part
of exon 7 (169 nt) (Fig. 1B). The template for the rTSa
riboprobe was DdeI linearized plasmid pTOPO/G4, pro-
duced by inserting a PCR fragment from H630 cell
genomic DNA corresponding to rTSa mRNA nt 1326–
1764 (Fig. 1A) into pCR2.1-TOPO (Invitrogen). The tem-
plate for making the cyclophilin (Cyc) riboprobe was
pTRI–Cyc–Human (Ambion). The lengths of TS, rTSa
and Cyc probes (and protected fragments) were 265 (251),
354 (285) and 165 (103) nt, respectively. All 32P-RNA
probes were produced by in vitro transcription using Maxi-
Script/T7 polymerase kits (Ambion) as recommended by
the manufacturer using [a-32P]CTP (800 Ci/mmol, 10 mCi/
ml, NEN Life Science Products). DNA templates were
removed by DNaseI digestion. All 32P-labelled riboprobes
were purified by 5% polyacrylamide/8 M urea gel electro-
phoresis. Specific radioactivities of the TS, rTSa and Cyc
probes used were 1.8109, 1.5109 and 8107 cpm/Ag,
respectively.
2.2. Cell culture and transfections
The HEp2 cell line (human epidermoid carcinoma,
ATCC CCL 23) was maintained in RPMI 1640 supple-
mented with 10% fetal bovine serum (Life Technologies) at
37 jC in a 5% CO2 humidified atmosphere. The HEp2 cell
line was chosen for study because of its low level of
endogenous rTSa expression and because of a robust
response to doxycycline (Dox) induction in preliminary
co-transient transfection assays using pUHD172-1 neo and
pUHC 13 3 (data not shown).
For the cell growth experiment (Fig. 2A), HEp2 cells
were seeded on multiple plates (8.0105 cells/10 cm plate)
and allowed to grow for different periods of time. Cells were
extracted to obtain both RNA and protein using TRIZOL
reagent (Life Technologies) as recommended by the manu-
facturer. For each time point, the cell number in a duplicate
plate was determined using a Coulter counter.
For transfections to establish the Tet-On gene expression
system, pUHD 172-1 neo was first stably transfected into
HEp2 cells using lipofectin (Life Technologies) as recom-
mended by the manufacturer. Clones were selected in the
presence of G418 (500 Ag/ml) and were screened for their
ability to be induced for luciferase expression by transient-
transfection assays. Clone P9E was Dox-inducible for
luciferase expression (100-fold), and was used in subse-
quent experiments. For each co-transient transfection with
pHook-1 (Invitrogen) [20] and one of the four constructs
(rTSa, rTSaD3VrTSa-3Vand luciferase, Fig. 3A), cells at
about 50% confluence were harvested and washed with ice-
cold PBS. The cell pellet was resuspended in ice-cold PBS
at a density of f 5.7 107 cells/ml, and 2.1 ml of cell
suspension was mixed with 150 Ag plasmid DNA (molar
ratio of pHook1/experimental construct = 10:1) and incu-
bated on ice for 10 min. The cells plus DNA mixture was
evenly transferred into three prechilled cuvettes (BTX, 4
mm gap). Electroporation was performed using a BTX
ECM 600 electroporator (400 V, 800 AF, 48 V). After the
pulse, the cuvettes were returned to ice for 10 min. The
electroporated cells were pooled and resuspended with
RPMI 1640 medium containing 10% fetal bovine serum
and 300 Ag/ml G418, and plated on 25 15-cm plates. After
20 h, transfected cells were selected with Capture-Teck
Beads (200 Al bead slurry, Invitrogen) as recommended by
the manufacturer. The selected cells (f 20% of total viable
cells) were plated at f 1.0 106 cells/10 cm plate and
returned to culture in the presence or absence of Dox (1.0
Ag/ml).
2.3. Western blot
Protein concentrations were determined using a BCAk
Protein Assay Kit with bovine serum albumin (BSA) as a
standard as described by the manufacturer (Pierce). Proteins
(35 Ag) were resolved by 10% SDS polyacrylamide gel
electrophoresis and immunoblotting was performed as pre-
viously described [21].
2.4. RNase protection assay (RPA)
RPA to measure TS mRNA or rTSa RNAwas carried out
using the HybSpeed RPA kit (Ambion) essentially as
described by the manufacturer. The amount of each probe
needed to achieve a molar excess over its target RNA was
determined by pilot experiments that established the linearity
of the assay. Cyc mRNA was also measured to serve as an
internal standard for quantitating protected fragments [22].
Briefly, 5 Ag of RNA, 6104 cpm of TS or rTSa riboprobe
and 3104 cpm of Cyc riboprobe were mixed and co-
ethanol-precipitated with yeast RNA (45 Ag) as carrier.
The RNA pellet was dissolved in 10 Al of hybridization
buffer by heating at 95 jC with vortexing. Hybridization was
performed at 68 jC for 18 h, and RNase digestions were
carried out at 37 jC for 40 min with RNase A/T1 (1:100),
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unless otherwise indicated. Protected fragments were
resolved by 5% polyacrylamide/8 M urea gel electrophoresis
and quantitated by phosphor screen imaging (Molecular
Dynamics Storm 860 with a setting of 750 V, 200 Am).
The lower specific activity of the Cyc probe allowed simul-
taneous quantitation of TS mRNA and rTSa RNA.
Fig. 2. Variation of TS protein, TS mRNA and rTSa RNA levels during asynchronous cell growth. (A) HEp2 cell growth. Cells were seeded at time 0 h
(8 105 cells/10 cm plate) and extracted at 19, 45, 67, 97, 116, 140, 166 and 194 h after seeding as described in Experimental procedures. The doubling time of
this cell line is 40 h. (B) Lanes 1–8: Proteins obtained from different time points of cell growth (19–194 h) were subjected to Western blot analysis for TS and
a-tubulin as described in Experimental procedures (left). The change of TS protein levels with cell growth normalized to a-tubulin is shown on the right. Panels
(C) and (D) are the results of RPA for TS mRNA and rTSa RNA, respectively. For all RPA experiments, Cyc mRNA was used as an internal standard. Left
panels show the phosphorimages of electrophoretic gels and positions of relevant protected fragments are indicated to the right of the images (TS, 251 nt TS
fragment; B, 195 nt TS fragment; C, 138 nt TS fragment; Cyc, 103 nt Cyc fragment; rTSa 285 nt rTSa fragment). Lanes 1–8: Cellular RNAs from different
time points of cell growth (19–194 h) were hybridized with TS and Cyc probes. M: pBR322/MspI molecular weight marker. Lanes P and C: The TS or rTSa
and Cyc probes were hybridized with yeast RNA either with (C) or without (P) RNase digestion. In lane P, discrete bands can be seen at the predicted lengths of
265 (TS), 354 (rTSa) and 165 nt (Cyc), whereas lane C shows complete digestion of unprotected probes. The graphs on the right show the molar ratios of TS
mRNA (B) or rTSa RNA (D) to Cyc mRNA at each time point of cell growth (calculated according to the formula given in Experimental procedures).
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2.5. Primer extension assay
Cellular RNA (20 Ag) was mixed with 0.1 Amol primer
(ACATTTGCCAGT-GGCAACAT, Fig. 1) and incubated at
70 jC for 5 min. The reverse transcription reaction (60 Al)
contained sample RNA, the primer, 10 mM DTT, 500 AM
each of dATP, dGTP, dTTP, 20 AM dCTP, 17 AM
[a-32P]dCTP (3000 Ci/mmol, 10 mCi/ml, NEN Life Science
Products), 1 first strand buffer (Life Technologies) and
400 units of Superscript II reverse transcriptase (Life Tech-
nologies). The reaction was carried out by incubation at
room temperature for 15 min followed by heating at 37 jC
for 1 h. The reaction was terminated and RNA hydrolyzed
by adding EDTA (40 mM) and NaOH (400 mM) and
heating at 68 jC for 30 min. The DNA products were
ethanol-precipitated, washed with 70% ethanol, and dis-
Fig. 3. RPA results for rTSa and rTSaD3Vtransiently transfected cells. (A) Time course analysis of rTSa RNA induction in rTSa transfected cells. (B,C) Time-
course analyses of TS mRNA levels in rTSa and rTSaD3Vtransfected cells, respectively. Panels are labeled as in the legend to Fig. 2. Lanes 1–12: RNA samples
obtained at 0–72 h after addingDox (0 and 1.0Ag/ml as indicated by ‘‘ ’’ and ‘‘ + ’’, respectively)were subjected toRPAas described in Experimental procedures.
R:RNAmarker (Ambion’s centurymarker). For each graph on the right, the solid linewith triangles represents induced cells (+Dox) and the dotted linewith circles
uninduced cells (Dox).
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solved in water. An excess amount of biotinylated TS
transcript generated from the HindIII linearized pTOPO/
G4 by T7 polymerase was added and the nucleic acid
mixture ethanol-precipitated. The pellet was dissolved in
10 Al of hybridization buffer (Ambion’s HybSpeed RPA kit)
by heating at 95 jC for 5 min with vortexing. Hybridization
was performed by incubation at 56 jC for 18 h. Streptavidin
superparamagnetic beads suspension (40 Al, Sigma) was
washed twice with 1.0 ml of TNE 300 (50 mM Tris–HCl,
pH 7.5, 1 mM EDTA, 0.1% SDS and 300 mM NaCl) and
resuspended in 100 Al TNE 300. Forty micrograms of yeast
RNA was added to the suspension and incubated at 37 jC
for 30 min with mixing by rotation. The pretreated strepta-
vidin beads in 100 Al of TNE 300 were added to the
hybridization reaction followed by incubation at 37 jC for
30 min with mixing by rotation. One milliliter of TNE 300
was then added and mixed well by vortexing. The super-
natant was removed after placing the tube in a magnetic
stand. This washing procedure was repeated five times at
which time the 32P-cpm in the supernatant decreased to
Fig. 4. Results for rTSa-3Vand luciferase transiently transfected cells. (A) Time course analysis of rTSa RNA induction in rTSa-3Vtransfected cells. (B,C)
Time-course analyses of TS mRNA levels in rTSa-3Vand luciferase transfected cells, respectively. Panels are labeled as in the legends to Figs. 2 and 3.
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background level. The bound 32P-cDNAs were then recov-
ered by heating the beads in 40 Al of gel loading buffer
(95% formamide, 18 mM EDTA, 0.025% SDS, xylene
cyanol and bromophenol blue) at 100 jC for 5 min and
resolved by 5% polyacrylamide/8 M urea gel electropho-
resis.
3. Results
3.1. TS mRNA levels decrease while rTSa RNA levels
increase as cell growth progresses from late-log to plateau
phase
It has previously been demonstrated that TS activity and
protein levels do not change much during the log-phase of
asynchronous cultured cell growth but decrease when cells
reach plateau phase growth [6,10]. To investigate whether
changes in TS mRNA levels behave this way in HEp2 cells,
and how rTSa RNA levels vary in relation to TS mRNA,
the levels of both TS mRNA and rTSa RNA during
asynchronous cell growth were determined by RPA. HEp2
cells were seeded and extracted at the indicated time points
to measure the levels of TS and rTS gene expression (Fig.
2). As shown in Fig. 2A, cell growth began to reach plateau
phase at 166 h after seeding. Consistent with previous
findings [6,10], the levels of TS protein fluctuated within
a narrow range (1.6-fold) during log-phase growth (45 to
116 h, Fig. 2B) but decreased 4-fold when cells transited
from late-log to plateau phase growth (140 to 194 h, Fig.
2B). In agreement with the decline in TS protein during the
transition to plateau phase, TS mRNA levels decreased 2-
fold (140 to 194 h, Fig. 2C). In contrast to TS mRNA, rTSa
RNA levels increased more than 3-fold when cells pro-
gressed from late-log to plateau phase (140 to 194 h, Fig.
2D). The inverse variation between the levels of TS mRNA
and rTSa RNA during the late-log and plateau stages of cell
growth (140 to 194 h, Fig. 2C,D) suggested a possible role
of rTSa RNA in the down-regulation of TS mRNA levels.
RPA for TS mRNA also showed the appearance of other
fragments smaller than the full-length protected probe (Fig.
2C). Two of these fragments (B, 195 nt and C, 138 nt) were
later found to correspond to in vivo TS mRNA cleavage
products.
3.2. TS mRNA levels can be down-regulated by rTSa
antisense RNA
To investigate the possibility that rTSa RNA can mediate
a decline in TS mRNA levels, cell transfections were
performed. Since we were unable to obtain a permanent
stably transfected cell line expressing rTSa [23], rTSa
transient co-transfections of HEp2 cells containing the Tet-
On transactivator [18] with pHook-1 and rTSa or rTSaD3V
were carried out. Co-transfection with pHook-1 allows
specific selection of transfected cells for evaluation [20].
After selection, cells were seeded in the presence or absence
of Dox and extracted at different time intervals to obtain
both RNA and protein. RPA clearly showed that increased
expression of rTSa RNA led to decreased TS mRNA levels
Fig. 5. Western blots showing rTSa and TS protein expression after transient transfections with rTSa (A), rTSaD3V(B), rTSa-3V(C) and luciferase (D). Each
blot was sequentially probed for rTSa, TS and a-tubulin as described in Experimental procedures. rTSa was not visible in the blots shown in panels C and D.
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(Fig. 3A,B). At 25 h post-Dox, the TS mRNA level
decreased by 80%. TS protein levels were also down
regulated by the increased expression of rTSa (Fig. 5A).
After 39 h post-Dox, rTSa RNA was still inducible with
Dox (Fig. 3A) but rTSa protein was no longer detected (Fig.
5A). This suggested that the down-regulation of TS mRNA
levels by the induced expression of rTSa was most likely
mediated by rTSa RNA rather than by rTSa protein. This
conclusion is supported by data obtained from transfections
performed with rTSaD3V, which contains the rTSa protein
coding region but does not have a region of RNA antisense
to TS RNA (Figs. 3C and 5B). Higher levels of rTSa
protein have been induced for a longer duration in compar-
ison with the rTSa mRNA transfected cells (Fig. 5B). The
effects of rTSa protein (rTSaD3V) induction differed from
those of rTSa mRNA. The rTSaD3Vtransfected cells did not
display significant changes in TS mRNA (Fig. 3C) but did
show alterations in TS protein levels after 39 h (Fig. 5,
compare B with C).
Down-regulation of TS by rTSa mRNA but not by rTSa
protein suggested that the 3V-antisense portion of rTSa RNA
might be sufficient for the observed negative regulation of
TS mRNA. To investigate this further, transient transfec-
tions with rTSa-3Vor luciferase were performed. While
increased expression of luciferase had no effect on the
levels of either TS mRNA (Fig. 4C) or protein (Fig. 5D),
induced expression of rTSa-3V resulted in decreased levels
of both TS mRNA (Fig. 4A,B) and protein (Fig. 5C).
3.3. rTSa RNA induces site-specific cleavage of TS mRNA
at physiologic cleavage sites
As shown in Fig. 2C, RPA of TS mRNA in non-
transfected HEp2 cells showed numerous smaller protected
fragments in addition to the full-length protected fragment
(251 nt). Interestingly, the intensity of two of these frag-
ments (B, 195 nt and C, 138 nt) were increased in rTSa
antisense RNA transfected cells in comparison with non-
transfected cells and rTSaD3Vor luciferase transfected cells
(Figs. 3B and 4B compared with Figs. 2C, 3C and 4C).
The levels of the 195 (B) and 138 nt (C) bands were found
to correlate with the levels of rTSa antisense RNA in
rTSa antisense RNA transfected cells. When rTSa or
rTSa-3Vtransfected cells were induced to express higher
levels of the antisense RNA (Figs. 3A and 4A), the levels
of these two smaller fragments relative to TS mRNA levels
also increased(Fig. 6). With the decline of rTSa antisense
RNA in uninduced cells during 72 h after seeding rTSa or
rTSa-3Vtransfectants (Figs. 3A and 4A), the intensity of
these two fragments also declined (Fig. 6). During the first
39 h, rTSa-3Vtransfected cells displayed higher, uninduced
levels of the antisense RNA compared with rTSa trans-
fected cells (Fig. 6, compare A and B). Correspondingly,
rTSa-3Vtransfected cells in the absence of Dox had an
increased relative abundance of these two bands (Fig. 6,
compare A and B).
The origin of the 195 (B) and 138 (C) nt protected
fragments could be cleavage of TS probe:mRNA hybrids
due to mismatches or transient destabilization (i.e., breath-
ing) during RPA or they could represent in vivo cleaved TS
mRNA molecules. Resolving these possibilities is important
because the complementarity of rTSa and TS RNAs sug-
gests that rTSa:TS RNA hybrids could form in vivo and
serve as substrates for adenosine deaminases that act on
RNA (ADAR) [16,24,25]. Our laboratory has identified five
editing sites (adenosine to inosine) in TS pre-mRNA in the
region of TS RNA complementary to rTSa RNA (unpub-
lished data). One editing site is predicted to generate a
mismatch with the 32P-labeled probe that would produce a
138 (C) nt protected fragment in the RPA (Fig. 1). The
abundance of this protected fragment along with the 195 (B)
nt fragment increased in response to elevated levels of rTSa
antisense RNA in rTSa and rTSa-3Vtransfected cells (Fig.
7), suggesting that the 138 (C) nt fragment could arise by
cleavage at an RNA editing site.
To verify that these two species (B and C) are not
cleavage products resulting from RNA duplex breathing
during RPA, RNase digestions were performed at different
Fig. 6. Levels of two protected fragments (i.e., B andC) relative to TSmRNA
from the time-course study of rTSa (A) and rTSa-3V(B) transfected cells. The
values in panels A and B are based on quantitations of the relevant protected
fragments as shown in the gel images of Figs. 3B and 4B, respectively. The
(B +C)/TS molar ratio is calculated as the sum of these two fragments (i.e.,
(B +C)/Cyc) divided by the amount of TS mRNA (i.e., TS/Cyc).
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stringencies by altering the temperature (0 to 37 jC). As
shown in Fig. 7A, the amounts of these two fragments
relative to TS mRNA remained unchanged over a wide
range of temperatures. The levels were relatively unchanged
even at 4 jC where the unprotected 3V-overhang of the TS
probe:TS mRNA duplex was not digested, leaving the entire
probe intact. This result suggests that the protected frag-
ments detected by our RPA are less likely to have been
produced in vitro by RNase digestions of unstable duplexed
regions of the TS probe:mRNA hybrids.
The likelihood that TS mRNAs are cleaved in vivo in
response to increased levels of rTSa antisense RNA was
investigated further using a primer extension assay. Cellular
RNA extracted from rTSa-3Vtransfected cells (39 h post-
Dox) were reverse transcribed using a TS gene specific
primer (Fig. 1) in the presence of [a-32P]dCTP. The 32P-
cDNA products are expected to have lengths reflecting TS
in vivo cleavage sites. If TS mRNA is cleaved in vivo, a
limited number of discrete 32P-cDNA fragments should be
detectable provided that the cleaved RNA molecules are
relatively stable during the time course of study. To mini-
mize the background generated from nonspecific priming,
TS 32P-cDNAs were selected by hybridization to biotiny-
lated TS RNA prepared by in vitro transcription. Hybridized
TS 32P-cDNAs were then purified by affinity chromato-
graphy with immobilized streptavidin. As shown in Fig. 7B,
increased amounts of TS 32P-cDNAs of 245 and 179 nt are
observed for primer extension performed with RNA from
transfected cells induced to express rTSa antisense RNA.
The size of the 32P-cDNA (245 nt) is that for a cDNA
produced from TS mRNA cleaved at one of the two editing
sites identified in exon 7 of TS pre-mRNA (unpublished
data) (Fig. 7C). This 32P-cDNA corresponds to the 138 (C)
nt RPA protected fragment (B and C in Fig. 4B). Therefore,
TS mRNAwas cleaved in vivo at an editing site in response
to rTSa antisense RNA. The 179 nt 32P-cDNA was the
result of extension to an adenosine site in an AU rich region
of TS mRNA as shown in Fig. 7C. This 32P-cDNA
corresponds to an in vivo cleaved TS mRNA molecule with
a cleavage site 9 nt downstream from the site that would
Fig. 7. (A) Results of RPA for TS mRNA performed with varying stringency of RNase digestion. Cellular RNA from rTSa-3Vtransfected cells was subjected to
RPA as described in Experimental procedures except that the RNase digestion step was performed over a range of temperatures (0–37 jC) as indicated. (B)
Results of primer extension assays. Assays were performed as described in Experimental procedures to detect in vivo generated TS mRNA fragments from
rTSa-3Vtransfected cells (with or without Dox). (C) Schema showing the protected fragments (195 and 138 nt) of RPA and their corresponding 32P-cDNA
products (179 and 245 nt) produced by the primer extension.
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generate the 195 nt protected fragment (B) observed in the
RPA. This difference probably reflects the AU-rich nature of
the intervening region between these two sites (Fig. 7C) that
likely gets degraded during the RPA (see Discussion).
4. Discussion
The rTS gene was originally identified by sequencing a
cDNA clone for a naturally occurring antisense RNA to
human TS mRNA [14]. These two genes are located at the
same locus of chromosome 18 [26]. The rTS gene overlaps
the 3Vend of the TS gene [27], and is transcribed conver-
gently with TS. Through alternative splicing, the rTS gene
transcript produces two mRNAs, rTSa and rTSh [28,29].
The 3VUTR of rTSa RNA is complementary to TS RNA
near its 3Vend including exon 7 and part of the last intron
(Fig. 1). As an initial investigation into the possible role of
rTSa RNA in the growth regulation of TS gene expression,
we first evaluated rTSa RNA and TS mRNA levels during
cell growth to determine their relationship. An inverse
relationship was found as cells progressed from late-log to
plateau phase (140 to 194 h in Fig. 2: C vs. D). In agreement
with the decline of TS mRNA levels, TS protein levels also
decreased (Fig. 3B). Although rTSa RNA levels increased
as cell growth progressed from late-log to plateau phase,
rTSa protein remained undetectable (data not shown). The
low-level expression of rTSa protein in HEp2 cells is
consistent with our previous observations for other human
tumor cell lines [21]. Because of the complementarity
between these two RNAs, the association between increased
rTSa RNA levels and decreased TS mRNA levels suggests
that rTSa RNA might be involved in the down-regulation of
TS gene expression.
The possibility that rTSa RNA down-regulates TS
mRNA was further investigated through transient transfec-
tions. Transient transfection experiments performed with
rTSa mRNA, rTSaD3V, rTSa-3Vand luciferase as the indu-
cible genes demonstrate that rTSa antisense RNA can
down-regulate the levels of TS mRNA. Increased expres-
sion of rTSa mRNA or rTSa-3Vbut not rTSaD3Vor lucifer-
ase (Figs. 3 and 4) resulted in decreased TS mRNA levels.
These results indicate that the antisense RNA portion of
rTSa RNA is both necessary and sufficient for the observed
down-regulation of TS mRNA levels.
In addition to the expected protected fragment (251 nt)
corresponding to a perfect hybrid of the 32P-probe with TS
mRNA, RPA of TS mRNA displayed other smaller frag-
ments. Among these smaller fragments, two discrete bands
(B, 195 nt and C, 138 nt) are of particular interest because
their intensities increased in the rTSa antisense RNA trans-
fected cells (Figs. 3B and 4B compared with Figs. 2C, 3C
and 4C). Further investigations into the nature of these two
fragments shed some light on the mechanism for rTSa
antisense RNA mediated down-regulation of TS mRNA
levels in transiently transfected cells and nontransfected
cells as well. There are three possible sources for the
appearance of these two bands. First, they might result from
the cleavage at some transiently destabilized regions of the
TS probe:mRNA duplex during RNase digestion. If this is
the case, the levels of these two bands relative to TS mRNA
should be identical among all the samples since they were
subjected to the same RPA procedure. Since their relative
abundance increased in response to the increased levels of
rTSa antisense RNA in transfected cells (Fig. 7) and were
not affected by altering the stringency of the RNase diges-
tion step of the RPA (Fig. 7A), this possibility can be ruled
out. Secondly, some mismatches in the TS probe:mRNA
duplex might be susceptible to RNase digestion thus leading
to the production of partial-length protected probes. In rTSa
antisense RNA transfected cells, the correlation between the
increased intensity of these two fragments and the elevated
levels of rTSa antisense RNA suggests that the antisense
RNA might induce TS mRNA modifications leading to
mismatches in the TS probe:mRNA hybrid. This possibility
is supported by the finding that TS pre-mRNA is edited
(adenosine to inosine) at five sites across the intron 6–exon
7 junction [30]. One editing site in the region targeted by the
32P-labeled TS probe (Fig. 1B) is predicted to generate a
mismatch that would produce a 138 nt protected fragment
upon cleavage in the RPA (Fig. 1B). Finally, it is also
possible that these two fragments might result from in vivo
cleaved TS mRNA molecules. This possibility is more
likely because the relative intensity of these two bands
remained at a similar level even when RNase digestions
were performed at temperatures when the mismatched
duplexes should be stabilized (Fig. 7A). The detection of
elevated levels of a 245 nt 32P-cDNA as a result of primer
extension of TS mRNA (Fig. 7B), corresponding to the 138
nt protected fragment in RPA (Fig. 7C), demonstrated that
TS mRNA was indeed cleaved in vivo and that cleavage
occurred predominantly at this editing site. Another 32P-
cDNA of 179 nt corresponds to an adenosine site of an AU-
rich region in TS mRNA (Fig. 7B,C). The RNA fragment
upstream of this in vivo cleavage site was detected by RPA as
the protected 195 nt fragment either because the AU-rich end
of the probe:mRNA duplex was susceptible to RNase di-
gestion or because the AU-rich region was degraded in vivo
subsequent to cleavage. The 126 nt fragment observed in
RPA may be derived from the 138 nt fragment due to RNase-
susceptibility of the AU-rich region (AAAAGUUGA) at the
end of the duplex formed between the TS probe and mRNA
(Fig. 7C). This appears to be likely since the 126 nt
fragment diminished in abundance with decreasing temper-
atures during RNase digestion (Fig. 7A). Consistent with
the RPA data, increased expression of rTSa antisense RNA
led to increased levels of both 32P-cDNA fragments of 245
and 179 nt, indicating that more TS mRNA molecules were
cleaved in vivo in response to the elevated antisense RNA
levels.
The 195 nt (B) and 138 nt (C) protected fragments in
RPA of TS mRNAwere also observed in the nontransfected
J. Chu, B.J. Dolnick / Biochimica et Biophysica Acta 1587 (2002) 183–193192
HEp2 cells (Fig. 2C). This suggests that the cleavage of TS
mRNA induced by rTSa antisense RNA in the transient
transfection assays also occurs in the more physiological
environment of nontransfected cells. One possible mecha-
nism for the demonstrated down-regulation of TS mRNA
levels by rTSa RNA is through duplex formation between
their complementary regions. In vivo hybrids have been
reported between antisense n-cym RNA and a subset of
sense n-myc RNA [31] and in the case of mbp sense and
antisense transcripts [32]. The current study provides the
evidence for one possible consequence of such duplex
formation, site-specific cleavage of TS mRNA. Antisense
(PSV-A) RNA-mediated RNA hybrid degradation resulting
in down-regulation of the sense RNA has also been impli-
cated in Dictyostelium [33]. It was thought that dsRNA-
specific RNases might exist in vivo and are responsible for
the rapid degradation of duplex RNAs. Indeed, enzymes
with this specificity have been described and partially
purified [34–36] but their physiological functions remain
to be established.
In summary, expression of rTSa RNA down-regulates
TS mRNA through an antisense-mediated mechanism. The
levels of rTSa antisense RNA and TS mRNA vary inversely
when cell growth progresses from late-log to saturation
phase (Fig. 2C,D). Additionally, increased expression of
the antisense RNA portion of rTSa but not rTSa protein
leads to decreased levels of TS mRNA (Figs. 3 and 4). One
of the contributors for this decline of TS mRNA is increased
site-specific cleavage, particularly at a TS RNA editing site
(Fig. 7), which also occurs in nontransfected cells. There-
fore, the negative regulation of TS mRNA levels by rTSa
RNA is likely mediated by increased TS RNA editing
followed by cleavage.
5. Conclusions and perspectives
Based upon the data presented here and the previous
observation that most rTSa RNA is nuclear, we suggest that
rTSa RNA could play a role in the down-regulation of TS
RNA in vivo. While induction of transfected rTSa antisense
RNA can cause the down-regulation of TS mRNA, we
suspect that the rTSa RNA acts to cause RNA editing with
either simultaneous or subsequent cleavage of the TS pre-
mRNAs at the editing site(s) in vivo. The implications for
chemotherapy will depend upon the mechanism used for the
activation of this pathway. For example, if the antisense
RNA is constantly in excess to the TS pre-mRNA in the
nucleus, then activation of this pathway by some signaling
mechanism suggests that this could be exploited in combi-
nation with small molecule inhibitors of TS to help prevent
new synthesis of TS protein (dependent upon turnover of
the TS mRNA). Our laboratory is actively pursuing this
possibility.
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